Johnson & Johnson Drops 3.4% to $245.87 Ahead of Earnings
As seen on the 24/7 Wall St. homepage on October 13, 2026.
A 3.4% slide to $245.87 is an outsized single day for a $592 billion defensive name, and it lands with earnings due today. The report arrives with the stock already repriced.
Continue ReadingShow less
Investors repriced Johnson & Johnson all session, leaving it at $245.87 before the results landed.
Selling pressure was persistent rather than concentrated in any single moment of the session.
Earnings were due the same day, so the earnings report arrives with the stock already carrying a roughly 3.4% discount to where it started the morning.
Defensive healthcare names rarely move this much in a day, making the earnings details worth close attention.
Sources
Mentioned: JNJ